Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: The low probability for cure

Journal of Clinical Oncology

Volumn 10, Issue 2, 1992, Pages 210-218

  Longo, D L ^a   Duffey, P L ^a   Young, R C ^a   Hubbard, S M ^a   Ihde, D C ^a   Glatstein, E ^a   Phares, J C ^a   Jaffe, E S ^a   Urba, W J ^a   DeVita Jr , V T ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; INTERLEUKIN 2; METHOTREXATE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ADULT; AGE; ARTICLE; CANCER RECURRENCE; COMBINATION CHEMOTHERAPY; FEMALE; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL;

EID: 0026558372     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1992.10.2.210     Document Type: Article

References (0)